Warren D C, Feehan P, Slade J B, Cianci P E
Department of Hyperbaric Medicine, 60th Medical Group, Travis AFB, California 94535-1800, USA.
Undersea Hyperb Med. 1997 Sep;24(3):181-4.
Chronic proctitis is a well-known complication of therapeutic irradiation. The results of hyperbaric oxygen therapy (HBO2) used in the treatment of chronic radiation proctitis are reported. From 1992 to 1995, 14 patients with chronic radiation-induced proctitis were treated with HBO2. Nine patients were treated in a monoplace chamber at 2.0 atm abs (203 kPa O2), and five patients were treated at 2.36 atm abs (239 kPa O2). Eight patients experienced complete resolution of symptoms and one patient had substantial improvement for a total response rate of 64%. Follow-up ranged from 5 to 35 mo. (mean 17 mo.). Five patients (36%) were classified as non-responders. Three experienced significant improvement during treatment but relapsed soon after therapy was discontinued, whereas two had no symptomatic improvement. Responders who had sigmoidoscopy after therapy showed documented improvement whereas no non-responders showed improvement. The authors conclude that HBO2 therapy should be considered in patients with chronic radiation proctitis.
慢性直肠炎是放射治疗中一种广为人知的并发症。本文报道了高压氧疗法(HBO2)用于治疗慢性放射性直肠炎的结果。1992年至1995年期间,14例慢性放射性直肠炎患者接受了HBO2治疗。9例患者在单舱内以2.0绝对大气压(203 kPa O2)进行治疗,5例患者以2.36绝对大气压(239 kPa O2)进行治疗。8例患者症状完全缓解,1例患者有显著改善,总有效率为64%。随访时间为5至35个月(平均17个月)。5例患者(36%)被归类为无反应者。3例患者在治疗期间有显著改善,但治疗停止后很快复发,而2例患者症状无改善。治疗后接受乙状结肠镜检查的有反应者显示有记录的改善,而无反应者则无改善。作者得出结论,慢性放射性直肠炎患者应考虑采用HBO2治疗。